Atlas Trials

Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia

Clinical trial NCT02614586 · TERMINATED

Trial details

NCT number
NCT02614586
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2015-12-01
Primary completion
2016-04-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.